Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies.
Saved in:
| Title: | Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies. |
|---|---|
| Authors: | Nacer A; Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Kivi G; Icosagen Cell Factory OÜ, Tartumaa, Estonia., Pert R; Icosagen Cell Factory OÜ, Tartumaa, Estonia., Juronen E; Icosagen Cell Factory OÜ, Tartumaa, Estonia., Holenya P; Research and Development, JPT Peptide Technologies GmbH, Berlin, Germany., Aliprandini E; Malaria Infection & Immunity Unit, Institut Pasteur, Paris, France., Amino R; Malaria Infection & Immunity Unit, Institut Pasteur, Paris, France., Silvie O; Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France., Quinkert D; Department of Biochemistry, University of Oxford, Oxford, United Kingdom., Le Duff Y; Centre for Aids Reagents, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Hurley M; Centre for Aids Reagents, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Reimer U; Research and Development, JPT Peptide Technologies GmbH, Berlin, Germany., Tover A; Icosagen Cell Factory OÜ, Tartumaa, Estonia., Draper SJ; Department of Biochemistry, University of Oxford, Oxford, United Kingdom., Gilbert S; Centre for Aids Reagents, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Ho MM; Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom., Bowyer PW; Division of Bacteriology, National Institute for Biological Standards and Control (NIBSC), Medicines and Healthcare products Regulatory Agency (MHRA), Potters Bar, United Kingdom. |
| Source: | Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2022 Jun 16; Vol. 12, pp. 901253. Date of Electronic Publication: 2022 Jun 16 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2235-2988 |
|---|---|
| DOI: | 10.3389/fcimb.2022.901253 |
